Anti-SARS-CoV-2 N humanized antibody (5B7)

Recommend MABX8404 for paired antibody immunoassay

SARS CoV2

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antibody can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

This human recombinant monoclonal Anti-SARS-CoV-2 N humanized antibody (5B7), Cat. No. MABX8406 is tested for use in ELISA, for the detection of SARS-CoV-2 Nucleocapsid.

Purified human recombinant monoclonal in buffer containing 20mM Tris and 50mM Glycine without preservatives.

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.